File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1186/s40364-023-00474-9
- Scopus: eid_2-s2.0-85152545305
- WOS: WOS:000961460600001
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: New insights into the function of Interleukin-25 in disease pathogenesis
Title | New insights into the function of Interleukin-25 in disease pathogenesis |
---|---|
Authors | |
Keywords | Autoimmune diseases Cancer Clinical treatment IL-25(IL-17E) Inflammation |
Issue Date | 1-Apr-2023 |
Publisher | BioMed Central |
Citation | Biomarker Research, 2023, v. 11, n. 1 How to Cite? |
Abstract | Interleukin-25 (IL-25), also known as IL-17E, is a cytokine belonging to the IL-17 family. IL-25 is abundantly expressed by Th2 cells and various kinds of epithelial cells. IL-25 is an alarm signal generated upon cell injury or tissue damage to activate immune cells through the interaction with IL-17RA and IL-17RB receptors. The binding of IL-25 to IL-17RA/IL-17RB complex not only initiates and maintains type 2 immunity but also regulates other immune cells (e.g., macrophages and mast cells) via various signaling pathways. It has been well-documented that IL-25 is critically involved in the development of allergic disorders (e.g., asthma). However, the roles of IL-25 in the pathogenesis of other diseases and the underlying mechanisms are still unclear. This review presents current evidence on the roles of IL-25 in cancers, allergic disorders, and autoimmune diseases. Moreover, we discuss the unanswered key questions underlying IL-25-mediated disease pathology, which will provide new insights into the targeted therapy of this cytokine in clinical treatment. |
Persistent Identifier | http://hdl.handle.net/10722/331724 |
ISSN | 2023 Impact Factor: 9.5 2023 SCImago Journal Rankings: 3.024 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yuan, QF | - |
dc.contributor.author | Peng, N | - |
dc.contributor.author | Xiao, F | - |
dc.contributor.author | Shi, XF | - |
dc.contributor.author | Zhu, B | - |
dc.contributor.author | Rui, K | - |
dc.contributor.author | Tian, J | - |
dc.contributor.author | Lu, LW | - |
dc.date.accessioned | 2023-09-21T06:58:21Z | - |
dc.date.available | 2023-09-21T06:58:21Z | - |
dc.date.issued | 2023-04-01 | - |
dc.identifier.citation | Biomarker Research, 2023, v. 11, n. 1 | - |
dc.identifier.issn | 2050-7771 | - |
dc.identifier.uri | http://hdl.handle.net/10722/331724 | - |
dc.description.abstract | <p> Interleukin-25 (IL-25), also known as IL-17E, is a cytokine belonging to the IL-17 family. IL-25 is abundantly expressed by Th2 cells and various kinds of epithelial cells. IL-25 is an alarm signal generated upon cell injury or tissue damage to activate immune cells through the interaction with IL-17RA and IL-17RB receptors. The binding of IL-25 to IL-17RA/IL-17RB complex not only initiates and maintains type 2 immunity but also regulates other immune cells (e.g., macrophages and mast cells) via various signaling pathways. It has been well-documented that IL-25 is critically involved in the development of allergic disorders (e.g., asthma). However, the roles of IL-25 in the pathogenesis of other diseases and the underlying mechanisms are still unclear. This review presents current evidence on the roles of IL-25 in cancers, allergic disorders, and autoimmune diseases. Moreover, we discuss the unanswered key questions underlying IL-25-mediated disease pathology, which will provide new insights into the targeted therapy of this cytokine in clinical treatment. <br></p> | - |
dc.language | eng | - |
dc.publisher | BioMed Central | - |
dc.relation.ispartof | Biomarker Research | - |
dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
dc.subject | Autoimmune diseases | - |
dc.subject | Cancer | - |
dc.subject | Clinical treatment | - |
dc.subject | IL-25(IL-17E) | - |
dc.subject | Inflammation | - |
dc.title | New insights into the function of Interleukin-25 in disease pathogenesis | - |
dc.type | Article | - |
dc.identifier.doi | 10.1186/s40364-023-00474-9 | - |
dc.identifier.scopus | eid_2-s2.0-85152545305 | - |
dc.identifier.volume | 11 | - |
dc.identifier.issue | 1 | - |
dc.identifier.eissn | 2050-7771 | - |
dc.identifier.isi | WOS:000961460600001 | - |
dc.identifier.issnl | 2050-7771 | - |